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Intestinal inflammation is a natural process crucial to maintain gut integrity, but its deregulation is 
involved in the pathogenesis of severe intestinal disorders
[1]
. Intestinal epithelial cells play a crucial 
role in the inflammatory response, modulating the immune cell exposure to antigens and by their 
ability to secrete many inflammatory mediators. IL-1β represents a pivotal player: secreted by 
infiltrated leucocytes, it induces the expression of several pro-inflammatory genes. Also the anti-
inflammatory IL-10, whose function is to terminate the inflammatory process, modulates the 
intestinal physiology
[2]
. Recent clinical reports showed that patients with ulcerative colitis in 
remission phase have significantly higher IL10 gene expression in mucosa compared with active 
patients and controls
[3]
. Moreover, in the latest years aberrant epigenetic mechanisms were put in 
binomial relationship with chronic inflammatory diseases
[4]
. 
Previously, we described a demethylation of pro-inflammatory IL6 and IL8 genes in human colonic 
Caco-2 cells differentiated into an enterocyte-like phenotype and exposed to the inflammatory 
action of IL-1β[5]. 
In the present study we evaluate whether the IL-1β treatment affected the methylation status of the 
anti-inflammatory IL10 gene, in the same in vitro model. Our results showed that IL-1β treatment 
did not change the hypermethylation status of the IL10 promoter. Moreover, in cell lysates from IL-
1β-treated Caco-2 cells, we observed a dose-dependent increase of DNMTs activity and, 
surprisingly, a decrease of DNMT3b expression. These findings put in evidence the complexity of 
relationship between IL-1β and DNMTs, and may suggest a potential role of IL-1β as pleiotropic 
modulator of DNA methylation in Caco-2 cell line. 
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